Abstract. Genes for the human a5(IV) and o~6(IV) collagen chains have a unique arrangement in that they are colocalized on chromosome Xq22 in a head-to-head fashion and appear to share a common bidirectional promoter. In addition we reported a novel observation that the COL4A6 gene is transcribed from two alternative promoters in a tissue-specific manner (Sugimoto, M., T. Oohashi, and Y. Ninomiya. 1994. Proc. Natl. Acad. Sci. USA. 91:11679-11683) . To know whether the translation products of both genes are colocalized in various tissues, we raised a5(IV) and a6(IV) chain-specific rat monoclonal antibodies against synthetic peptides reflecting sequences near the carboxy terminus of each noncollagenous (NC)I domain. By Western blotting a6(IV) chain-specific antibody recognized 27-kD monomers and associated dimers of the human type IV collagen NC1 domain, which is the first demonstration of the presence in tissues of the ot6(IV) polypeptide as predicted from its cDNA sequence. Immunofluorescence studies using anti-oL6(IV) antibody demonstrated that in human adult kidney the tx6(IV) chain was never detected in the glomerular basement membrane, whereas the basement membranes of the Bowman's capsules and distal tubules were positive. The staining pattern of the glomerular basement membrane was quite different from that obtained with the anti-o~5(IV) peptide antibody. The o~5(IV) and a6(IV) chains were colocalized in the basement membrane in the skin, smooth muscle cells, and adipocytes; however, little if any reaction was seen in basement membranes of cardiac muscles and hepatic sinusoidal endothelial cells. Thus, both genes are expressed in a tissue-specific manner, perhaps due to the unique function of the bidirectional promoter for both genes, which is presumably different from that for COL4A1 and COL4A2.
B
ASEMENT membranes are continuous sheets of specialized extracellular matrix composed of collagen IV, laminin, nidogen, heparan sulphate proteoglycan, and other glycoproteins that are found wherever cells meet extracellular matrix (Rohrbach and Timpl, 1993) . This means that basement membranes are located outside of most of the cells: at the dermal-epithelial junction; at the base of all lining epithelia throughout the digestive, respiratory, reproductive, and urinary tracts; underlying endothelia of capillaries and venules; around Schwann cells, adipocytes, skeletal, cardiac, and smooth muscle cells; and at the base of parenchymatous exocrine and endocrine glands (Junqueira et al., 1992) . Thus, they are the natural substrates on which most of the cells except blood cells grow and develop. They closely adjoin and are products of the overlying cells, and serve to compartmentalize the extracellular matrix and provide a barrier between cells and matrix.
Collagen type IV is a major structural component of basement membrane. The major form of this protein is a heterotrimer containing ed(IV) and ot2(IV) chains, and this form appears to be ubiquitous in all basement membranes (Rohrbach and Timpl, 1993) . Microsequencing of peptides made it possible to identify the human tx3(IV) and et4(IV) chains (Wieslander et al., 1985; . The primary structure of the human a3(IV) chain has been reported just recently and cDNAs encoding the entire human a4(IV) chain have been isolated and characterized as well Leinonen et al., 1994) . Lately, the nature of the tx5(IV) chain has been identified by cDNA isolation Zhou et al., 1992) , and linkage between the e~5(IV) gene (COL4A5) and Alport's Syndrome has been clarified (Barker et al., 1990) . Zhou et al. (1993) and Oohashi et al. (1994) cloned genomic DNA and cDNAs coding for yet another c~(IV) chain, cx6(IV). These newly discovered c~ chains still contain the amino-terminal 7S domain, the central COL1 domain, and the carboxy-terminal noncollagenous (NC)I n domain as found in the classical cd(IV) and a2(IV) chains; however we do not know the mechanism to explain which of the six c~ chains are selected, or how they come together, to form collagen type IV molecules.
Of interest is that the genes encoding the six individual c~ chains in humans are paired by two on three different chromosomes: the cxl(IV) gene (COL4A1) and the e~2(IV) gene (COL4A2) are located on chromosome 13 (Pihlajaniemi et al., 1985; Boyd et al., 1988; Griffin et al., 1987) ; COL4A3 and COL4A4 are on chromosome 2 Kamagata et al., 1992) ; and COL4A5 and COL4A6 are on chromosome X Zhou et al., 1993; Oohashi et al., 1994) . Further, COL4A1 and COL4A2 are aligned in a head-to-head fashion sharing a common promoter between the two genes (Poschl et al., 1988; Soininen et al., 1988) , whereas the precise upstream structure of COL4A3 and COL4A4 has not been reported yet. COL4A5 and COL4A6 have been found together on chromosome X at the segment q22 Zhou et al., 1993; Oohashi et al., 1994) and have been reported to be also arranged in a head-to-head fashion and to share a bidirectional promoter (Zhou et al., 1993) . Furthermore, we reported the novel observation that the COL4A6 gene is transcribed from two alternate promoters in a tissue-specific fashion .
Presently we report for the first time the presence of the COL4A6 gene products as detected by Western blotting and immunofluorescence staining of various tissues by use of peptide-specific monoclonal antibodies. Our results demonstrate that the COL4A5 and COL4A6 genes are not necessarily coexpressed in several types of tissues.
Materials and Methods

Synthetic Peptides
Earlier we determined the complete primary structure of the human a6(IV) chain Zhou et al., 1994) . When the amino acid sequences of all six a(IV) chains were compared, their noncollagenous (NC)1 domain portions showed the highest homology with each other. However, the amino acid sequences of certain subregions of NC1 were quite different from one another. We selected the peptide TI'VEER-QQFGELPVSETLKAGQLHTRV from the c~6(IV) chain and ATVDVSDMFSKPQSETLKAGDLRTRIS from the e~5(IV) chain , both of which are close to the carboxyl ends, as shown in Fig. 1 . We also synthesized a peptide, CPST-GELEFMGFPKG, derived from the third imperfection of the GIy-X-Y repeating sequence in the COL1 domain of the c~6(IV) chain. A cysteinyl residue was added at the amino terminus to allow coupling of the peptide to the carrier protein. Oligopeptides were chemically synthesized by the solid-phase procedure of Merrifield (1963) . Arrows indicate the direction of the transcripts for COL4A5 and COL4A6. There are two transcriptions for COL4A6. One transcription start site (from exon 1') for COL4A6 is 442 bp away from the transcription start site of COL4A5, while an alternative transcription start site (from exon 1) is located 1050 bp apart from the first one and drives the expression of a second transcript that encodes an e~6(IV) chain with a different signal peptide. (Bottom) Because of the direction of the two genes, the translation products, a5(IV) and c~6(IV) chains, of the two genes are drawn accordingly. Chain-specific monoclonal antibodies were raised against synthetic peptides (short bars) of the NC1 domains close to the carboxyl termini of the two chains. The third peptide deduced from the third imperfection of the Gly-X-Y repeating sequence in the central COL1 domain was synthesized and used for monoclonal antibodies. The sequences of the three synthetic peptides are shown with cysteinyl residues at the amino termini. Using the Geysen's peptide scanning technique (Geysen et al., 1987) we determined the exact location of the epitopes for H61, H62, and H63. Relative location of the epitopes are shown by three thick bars under the c~6(IV) peptide. limpet hemocyanin, by the maleimide method (Ishikawa et al., 1983) . In some experiments the peptides were directly used as antigen without conjugation to hemocyanin, and the antigenic efficiency was found not to differ much. Other peptides, ATIERSEMFKKPTPSTLKAGELRTHVS from the al(IV) chain (Pihlajaniemi et al_ 1985) , TTIPEQSFQGSP-SADTLKAGLIRTHIS from the e~2(IV) chain , ASLNPERMFRKPIPSTVKAGELEKIIS from the c~3(IV) chain (Morrison et al., 1991) , and TVKADFEFSSAPAPDTLKESQAQR-QKI from the c~4(IV) chain (Sugimoto et al., 1993) , were used for raising chain-specific antibodies against the other human c~ chains.
Peptide-specifie Monoelonal Antibodies
We introduced new steps to our previous method and developed a new efficient procedure, the rat lymph node method, for raising monoclonal antibodies (Kishiro et al., 1995) . Briefly, WKY/NCrj rats (Charles River Japan, Yokohama, Japan) were immunized in the hind foodpads with 50 mg of hemocyanin-coupled synthetic peptide emulsified with Freund's complete adjuvant. Three or four weeks later the rats were killed, and Iymphocytes obtained from the medial iliac lymph nodes of the rats were fused with mouse myeloma cells (SP2/0-Ag14). Supernatants from hybridoma cultures were screened by ELISA, using hemocyanin-free peptides from individual a(IV) chains.
The initial screening was performed by EIISA with the synthetic peptides themselves and/or native NC1 fractions isolated from the human kidney and other peptides of the same region from all c~(IV) NCI domains. 2,000 clones were screened and we picked 145 positive clones that reacted specifically with the c~6(IV) peptide. The second screening was performed by indirect immunofluorescence using human tissue sections. Thus, three clones, H61, H62, and H63, out of the 12 positive clones for both ELISA and immunofluorescence were established.
Preparation of the NC1-Domain Fraction from Renal Basement Membrane
Renal basement membrane was prepared by the same method as that used for bovine renal basement membrane (Sado et al., 1991) . In order to recover the NC1 domains from the collagen IV molecules we used bacterial collagenase and removed the central collagenous (COL) domains from the molecules. Namely, lyophilized basement membrane was solubilized with collagenase (Seikagaku Kogyo, Tokyo, Japan) at 47°C for 20 h by a method similar to that used for bovine nephritogenic antigen. After solubilization, the sample was centrifuged at 27,000 g for 10 min and insoluble material was removed. The supernatant was dialyzed against distilled water for 8 h, lyophilized, dissolved in PBS, and dialyzed against PBS overnight. The material was then centrifuged to remove insoluble materials formed during the dialysis. The supernatant was applied to a gel filtration column of UltrogelAcA 34(26 x 950 ram) at a flow rate of 30 ml/h. The main peak fraction was coilected and concentrated.
Western Blotting
The NC1 fractions of collagen type IV thus prepared were analyzed by SDS-polyacrylamide gel electrophoresis under nonreducing conditions (Laemmli, 1970) . SDS-containing 5% stacking and 11.5% homogeneous running polyacrylamide slab gels were used. Proteins separated on the SDS gels were blotted onto polyvinylidene difluoride (PVDF) membranes. The membrane was incubated with the primary antibodies first and then with the peroxidase-conjugated secondary antibodies (Sado et al., 1991) .
Immunohistochemical Staining
Indirect immunofluorescence staining were performed as described previously (Sado et al., 1991) . In the preliminary experiments we have tested different conditions varying the concentration of the urea, pH, incubation time, and temperature using the representative tissues including kidney, muscles, and skin. We set up to the standard acid-urea denaturation condition: incubating ethanol-fixed sections with 6 M urea-HC1 buffer (pH 3.5) for 1 h at room temperature. 6 M urea treatment is necessary for most of the antibodies probably due to the linearized synthetic peptide antigens. Control sections for immunofluorescence staining were reacted with nonimmnne rat sera or with the secondary antibody alone. These controls were negative.
The staining method for the kidney and skin. Normal portions of human kidneys were obtained from two patients with renal tumors (both males, 56 and 85 yr old). Renal biopsies were performed from two AIport's syndrome patients (males, 14 and 9 yr old). Skin specimens were obtained from the patients with Alport's syndrome and from patients with nonrenal diseases by surgical biopsy.
The tissues from the kidney and skin were snap-frozen in liquid nitrogen. 3-ram cryosections were fixed with acetone for 10 min. To reveal possible masked epitopes, we pretreated the sections with 6 M urea in 0.1 M glycine-HC1 buffer (pH 3.5) for 10 min at room temperature. After having been washed with PBS, the sections were incubated with monoclonal antibodies for 1 h at room temperature. After another washing with PBS, they were incubated with FITC-labeled goat anti-rat IgG (Cappel Labs., Cochranville, PA) for 1 h, and then were examined under a fluorescence microscope (Axiophot, Zeiss, Germany). Control sections were treated by the same protocol except for the step of the incubation with the monoclonal antibody.
The staining for the extrarenal tissues. Various organs obtained from an autopsy case (64-yr-old female) were used as normal tissues. Acid-urea denaturation was performed by incubating acetone-fixed sections with 0.1 M glycine-HCl buffer (pH 3.5) containing 6 M urea for 2 to 30 min at room temperature. Positive control sections were stained with anti-cd(IV) or a2(IV) collagen antibody, as it is well known that both al(IV) and a2(IV) chains are usually colocalized in basement membrane. Negative control sections were reacted with non-immune rat sera, with the secondary antibody alone, or with the primary antibody preabsorbed with the synthetic peptide.
Alport's Syndrome Patients
We examined two cases of Alport's syndrome diagnosed by clinical manifestations and histological examinations. One case, a 14-yr-old boy, had proteinuria, hearing loss, and eye lesions. Electron microscopic examination of the glomeruli showed basement membrane thickening with lamination and splitting. The second case, a 9-yr-old boy, had proteinuria (0.2~.6 g/d) and hematuria since the age of three years. He displayed farsightedness of the eyes and hearing loss as well. Several relatives had renal diseases, and some of them had died. Histological and electron microscopic examination of the kidney demonstrated irregular thickening of the glomerular basement membrane, confirming the diagnosis.
Results
Production of a6(IV) Chain-specific Antibodies
We selected a relatively nonconserved region, close to the carboxy termini of the NC1 domains, as a pattern to prepare synthetic peptides for use as immunogens to elicit a(IV) chain-specific monoclonal antibodies. Keyhole limpet hemocyanin (KLH)-conjugated peptide emulsified with Freund's complete adjuvant was injected into hind footpads, and medial iliac lymph nodes of the immunized rat were used for fusion with myeloma cells. For a6(IV)-specific antibodies we repeated the cell fusion five times. In each experiment fused cells were plated on four 96-well plates. 145 positive wells from the five experiments were obtained by direct reaction with the synthetic peptides. We further screened by staining frozen sections of human kidney and selected 12 strongly positive clones, which were then tested with the synthetic peptides from the same region of the other cd through c~5 chains by ELISA. All of the 12 clones were specific for the a6(IV) chain. Three antibody clones out of these 12 clones for the ~6(IV) peptide, H61, H62, and H63, were established after subcloning by limiting dilution. Monoclonal antibodies Hll, H21, H31, H43, and H52 to the human cd(IV), R2(IV), ~3(IV), a4(IV), and a5(IV) chains, respectively, were also obtained in the study. Significant similarity was not found between the peptide sequences used for antibodies and the known amino acid sequence in proteins by DDBJ or Swiss Plot sequence analysis. The specificity of the antibodies against the synthetic peptides was tested by ELISA. A typical specific reaction of each antibody to individual antigen peptides is demonstrated in Fig. 2 . Using the Geysen peptide scanning technique (Geysen et al., 1987) , we narrowed down the epitopes for H61, H62, and H63 to the amino acid sequences of VSETLK, FGEL, and GELP, respectively, within the synthetic peptide sequence. Relative location of the epitopes for H61, H62, and H63 is drawn in Fig. 1 .
Immunoblot Analysis
The structure of the entire human et6(IV) collagen polypeptide was predicted by cDNA sequence analysis . The deduced collagen polypeptide contained 1690 amino acid residues, including a 21-residue signal peptide, a 24-residue amino-terminal NC domain, a central 1417-residue collagenous (COL1) domain, and a 228-residue carboxy-terminal NC1 domain. To detect the presumptive peptide at the protein level we utilized monoclonal antibody H63, specific for the eDNA-derived polypeptide that was mentioned above. Kidney was used as the starting material for Western blotting analysis. Since the predicted ~t6(IV) collagen polypeptide structure was simi- , and dH20 (lane 8) were added to the wells individually and incubated for 1 h. After the unbound antibodies had been washed out, the individual wells were blocked with bovine serum albumin. The peroxidase-conjugated secondary antibodies were added to all of the wells and reacted for 1 h. Note the specific reactions between the antigens and antibodies even though there is some similar sequence between peptide sequences used for raising the monoclonal antibodies. lar to that of the other known e~ chains of collagen IV, we digested away the central collagenous domain by bacterial collagenase; and the materials were then electrophoresed and transferred to P V D F membranes. The membrane strips containing the blotted protein were incubated with antibody H63 made against the c~6(IV)-derived peptide (see Materials and Methods). As shown in Fig. 3 , the antiserum stained a band of ~27 kD in size, which is consistent with the NC1 size of the c D N A -d e r i v e d u6(IV): 228 residues with a calculated molecular weight of 25,418 . This staining was blocked by preincubation of the antiserum with the antigen (data not shown). Preimmune serum was completely negative. W h e n the other five antibodies against cd(IV) through a5(IV) peptides were reacted as controls with the same materials, several bands similar in size to those seen with c~6(IV) sera and relatively distinct bands detected by t~l to c~5 sera were obtained. The size of these bands was also reason- Figure 3 . Western-blot analysis for the NCl-domain fraction from renal basement membrane. The NCl-domain fraction was prepared from renal basement membrane (see Materials and Methods), and SDS-PAGE was conducted on 11.5% polyacrylamide gels. After blotting of the proteins onto a PVDF membrane, the membrane was sliced into seven strips. Lanes 1 and 8 were stained with Coomasie-Brilliant Blue, and the rest of them were incubated with the individual a chain-specific monoclonal antibodies. Lanes 2-7 were incubated with H l l , H21, H31, H43, H52, and H63, respectively. Note the sizes of the reactive peptides are different from strip to strip. The sizes of the peptides for lane 6 (for a5(IV)NC1) and 7 (for a6(IV)NC1) are estimated as ~26 and 27 kD, respectively. Several reactive peptides around the size of 50 kD probably represent dimerized forms. able for each NC1 domain. Each antibody also detected some bands at ~5 0 kDa, which we consider to be the dimeric forms (Johansson et al., 1992) . Thus, a6(IV) antibody reacted indeed with the NC1 domain of the a6(IV) polypeptide, which is the first demonstration of the presence of the polypeptide in human kidney.
Indirect Immunofluorescence Staining of Kidney Basement Membranes with Monoclonal Antibody against ~6(IV)-derived Peptide
Immunofluorescence studies on frozen sections of human adult kidney with the c~6(IV) peptide antiserum surprisingly gave a negative reaction in the glomerular basement membrane, whereas the basement membrane of the Bowman's capsules and of some tubules was positive, as shown in Fig. 4 F. The staining was completely blocked by preincubation of the antibody with the ct6(IV) peptide used for raising antibody, H63 (Fig. 5 B) . This staining pattern was quite in contrast with that obtained with the c~5(IV) peptide antiserum (Fig. 4 E) , in which basement membranes of glomerulus, Bowman's capsules, and some tubules were all positive. Thus, the two genes COL4A5 and COL4A6, controlled by a bidirectional promoter, are not always expressed at the same time; the cells that produce glomerular basement membrane express the c~5(IV) gene but not the c~6(IV) one at least in adult humans. Control experiments confirmed the specificity of these staining reactions. No reaction was obtained with the preimmune sera (data not shown). In contrast, antisera against cO(IV) and oL2(IV) peptides gave a strong and similar staining pattern of all basement membranes of the glomeruli, tubules, and Bowman's capsules as well (Fig. 4, A and B) . Intriguingly, the staining pattern for c~3(IV) and et4(IV) antibodies was the same; both strongly stained the glomerular basement membrane and some distal tubules but mostly gave faintly positive reactions for basement membranes of Bowman's capsules (Fig. 4, C and D) . The staining pattern for the kidney is summarized in Table I . Figure 4 . Differential staining of kidney basement membranes obtained with a(IV) chain-specific antibodies, a(IV) chain-specific antibodies were used to stain kidney basement membranes. Antibodies of Hll, H21, H31, H43, H52, H63, and H64 were used for photos A-F, respectively. Note that cd(IV) and c~2(IV) chains are coexpressed in all of the basement membranes in the kidney: glomeruli, Bowman's capsu!es, distal tubules, proximal tubules, and some capillaries. Antibodies specific for c~3(IV) and a4(IV) chains demonstrated rather restricted staining pattern, i.e., glomerular, some tubular basement membranes; however these two chains are expressed together. Interestingly, c~5(IV) and a6(IV) chains are not coexpressed; no staining for ~6(IV) chain is seen in glomerular basement membrane (F), whereas c~5(IV) chains are clearly expressed in the glomerulus (E).
To confirm that the monoclonal antibodies are recognizing the e~6(IV) chain, we have done two experiments. One of them was to define the epitopes of the H61, H62, and H63 antibodies using Geysen's technique (Geysen et al., 1987) . As mentioned above, the epitope sequences of VSETLK, FGEL, and G E L P for H61, H62, and H63 antibodies, respectively, were all within the original peptide sequence but different from each other. However, the immunostaining pattern using the antibodies for the kidney sections were the same (data not shown). This suggested that the different antibodies recognizing different epitopes were reacting with the same molecule. The second experiment was to raise monoclonal antibodies to the peptide sequence within the COL1 domain of the a6(IV) chain. We selected C P S T G E L E F M G F P K G in the third imperfection of the GIy-X-Y repeating sequence (IV) a2(IV) a3(1v) a4(1v) c~5((v) a6(1v +, weakly positive; + +, moderately positive; + + +, strongly positive; -, negative. * Not all the tubular basement membrances were positive for c~3(IV), a4(IV), a5(IV), and a6(IV) antibodies.
within the COL1 domain. A m o n g 11 positive clones by ELISA, the two clones, H64 and H65, were subcloned and purified. The immunostaining pattern for the kidney section using these two clones was the same as that of H63 shown in Fig. 5 . These results indicate that the different antibodies derived from the different sequences still recognize the same material, the a6(IV) chain, in the tissues.
Differential Localization of the a5(IV) and a6(IV) Chains in Tissues Outside of the Kidney
To investigate whether the two genes are expressed in basement membranes in tissues other than the kidney, we stained several other organs and tissues, as shown in Fig. 6 .
Skin. Epidermal basement membranes are thought to
be produced by the keratinocytes, aligning at the base of the epithelial layers. Since the staining pattern for the cd(IV) and ct2(IV) chains were almost the same, only the ct2 staining pattern is shown in Fig. 6 A. As shown in Fig. 5 , B and C, this basement membrane was stained by both antibodies against ct5(IV) and c~6(IV) chains, indicating that the keratinocytes express both genes together in human adult skin.
Muscle. Esophageal smooth muscle, cardiac muscle, and abdominal skeletal muscle were examined by using antial(IV), -c~2(IV), -a5(IV), and -a6(IV) antibodies. Both a5(IV) and a6(IV) chains colocalized in the basement membranes of the smooth muscle cells (Fig. 6, E and F) . However, these two chains were never detected in cardiac muscle cells (Fig. 6, H and I ), although both a l ( I V ) and a2(IV) chains were stained substantially (Fig. 6 G) . Unexpectedly, in basement membranes surrounding the skeletal muscle cells, et5(IV) was negative and a6(IV) was weakly positive (Fig. 6 L) when the sections were stained with H-61 antibody. Further, this staining was blocked by incubating the antibody with the synthetic peptide of the c~6(IV) chain. Relative to the a2(IV) staining, the c~6 staining intensity was quite weak; therefore the level of the c~6(IV) chain is presumed to be fairly low.
Adipocytes. Adipocytes expressed both a l ( I V ) and e~2(IV) chains strongly (Fig. 6 M) . Since aS(IV) and a6(IV) staining was quite low (Fig. 6, N and O) , we had to expose the film longer to get a clear staining pattern. The level of e~5(IV) and a6(IV) expression around adipocytes also thus appears to be quite low.
Liver. cx2(IV) chain was present in the space of Disse ( Fig. 6 P) ; however, neither a5(IV) nor ~6(IV) chains were detected in this space underneath the sinusoidal endothelial cells (Fig. 5, Q and R) . Table II provides a summary of the above-mentioned staining patterns.
aS(IV) and a6(IV) Chains in Basement Membranes of Alport's Syndrome Patient
Immunohistochemical analysis was performed in kidney and skin from patients with X-linked Alport's syndrome. As shown in Fig. 7 , antibodies against a l ( I V ) (photo not shown) and a2(IV) chains clearly stained basement membranes in glomeruli, Bowman's capsules, and tubules. However, neither of the antibodies against the a5(IV) and a6(IV) chains stained the basement membranes in the Alport kidney (Fig. 7, B and C) . Antibodies against Figure 5 . Staining of kidney basement membranes by c~6(IV) antibodies. Serial sections of human kidney were stained by the two monoclonal antibodies to the different part of the a6(IV) chain: one (H63) is to the synthetic peptide from the NC1 domain (A) and the other (H65) is to the COL domain (C). Note the staining pattern using the two monoclonal antibodies is the same. Positive fluorescence staining using H63 antibody was completely blocked by the original synthetic peptide, TTVEER-QQFGELPVSETLKAGQLH-TRV(B). D shows nonstained phase contrast microscopic image of the neighboring section. a3(IV) and a4(lV) chains also did not give positive staining in basement membranes in the kidney of the two patients examined (data not shown).
Table II. Distribution of Type IV Collagen al (IV), a2(IV), a5(IV), a6(IV) Chains in Basement Membranes of Extrarenal Tissues
In Fig. 8 , distribution of a(IV) chains in skin specimens from a normal individual and an Alport patient is shown. Antibodies against al(IV) and a2(IV) chains demonstrated a clear linearized staining pattern in the epidermal basement membrane and basement membranes around capillaries and sweat glands in normal skin. a5(IV) and a6(IV) chains were detected only in the basement membrane of the epidermis but not in basement membranes around capillaries and sweat glands. In contrast to the normal skin, Alport skin showed negative staining with c~5(IV) (Fig. 8 H) and a6(lV) (Fig. 8/) antibodies in epidermal basement membranes, whereas cd(IV) (data not shown) and a2(IV) (Fig. 8 G) antibodies clearly stained the basement membranes.
Discussion
Diversity has been revealed among the subunits that form collagen IV molecules with the discovery of the cx3, ct4, et5, and cx6 chains (Hudson et al., 1993) . But chain assemblies that make up type IV molecules have been difficult to demonstrate since the c~3-a6(IV) chains were studied primarily in the context of the disease-related human tissues. The cx3(IV) chain was discovered as the Goodpasture antigen, which attacks primarily the alveolar basement membranes in the lung and the glomerular basement membranes in the kidney (Butkowski et al., 1987) . Further, trials to purify the cx3(IV) chain resulted in the discovery of another a-chain, a4(IV) (Gunwar et al., 1990) . cDNA cloning of these two chains led to the identification of mutations in COIAA3 and COL4A4 in patients with autosomal recessive type Alport syndrome Lemmink et al., 1994) . Most recently COIAA6 was shown to be located next to COIAA5 (Zhou et al., 1993; and both genes were mutated in several X-linked cases of Alport syndrome combined with leiomyomatosis (Zhou et al., 1993) .
Immunohistochemical analyses have shown that the al(IV) and a2(IV) chains are abundant in all tubular basement membranes and in the glomerular mesangial matrix (Kleppel et al., 1989) . However the a3-a5(IV) collagen chains have a rather limited distribution in human tissues; highly enriched in glomerular basement membranes but found only in a subset of tubular basement membranes Sanes et al., 1990; Hudson et al., 1992; Yoshioka et al., 1994) . Just recently, Miners and Sanes (1994) reported the distribution of a3, a4, and a5(IV) collagen chains in rodent basal laminae. They suggested from their immunohistochemical studies of various tissues that many combinations of a(IV) chains were possible, but a3 and a4(IV) chains were always coexpressed together, and appeared only in basal laminae that were a5(IV) chain positive. However, they did not examine the distribution of the newly discovered et6(IV) chain with respect to the other a(IV) chains. In the light of gene regulation of the two neighboring genes, COIAA5 and COIAA6, we herein examined and focused on the expression of the two genes at the protein level.
We first raised monoclonal antibodies specific for the human a6(IV) collagen chain and used them with antibodies produced by a previously isolated clone for a5(IV) chain to identify location of a5(IV) and a6(IV) chains in basement membranes of kidney, skin, muscle, liver, and fat cells. In addition, we used the monoclonal antibodies to identify the NC1 domains of a5(IV) and a6(IV) by Western blotting.
Our immunohistochemical survey with monoclonal antibodies to a5(IV) and a6(IV) chains indicated a very restricted distribution of these proteins in basement membranes. The basement membrane in the glomerulus is physiologically and clinically a carefully studied matrix. This basement membrane contains specialized structures that face cell layers of epithelial cells and endothelia or other cells on both surfaces. As shown in Fig. 4 , the glomerular basement membranes were strongly positive when stained with a5(IV) chain-specific antibody, H51; however, antibody against the a6(IV) peptide did not show a fluorescence staining within the glomerular basement membrane. In contrast, basement membranes in Bowman's capsule and distal tubules were positive with both antibodies. There are at least two and possibly more different molecular forms in the glomerulus: [al(IV)]2a2(IV) and one or more molecular forms of the combination of a3, a4, and a5 chains. In an Alport's nephritis case, neither of the Figure 6 . Staining of basement membranes in extrarenal tissues using al(IV)/a2(IV), cx5(IV), and o~6(IV) antibodies. Expression of cd(IV), and a6(IV) chains was examined in basement membranes in extrarenal tissues; skin (A-C), smooth muscle cells (D-F), cardiac muscle cells (G-/), abdominal skeletal muscle cells (J-L), adipocytes (M-O), and liver (P-R). Since antibodies for al(IV) and a2(IV) chains gave quite similar patterns, only the a2(IV) staining pattern using H21 is shown in A, D, G, J, M, and P. Expression of a5(IV) (B, E, H, K, N, and Q, using H52 antibody) and a6(IV) (C, F, L L, O, and R, with H63 antibody) chains is compared in various basement membranes. Around the smooth muscle cells and at the epidermal/dermal junction, the ~x5(IV) and c~6(IV) chains are coexpressed, but no expression of these genes was detected in cardiac muscle and liver. Intriguingly, only a6(IV) is weakly stained in skeletal muscle, whereas no staining is detected for a5(IV) chain. three chains, a3, or4, and a5, were found in the glomerulus (Fig. 6) . We do not know the precise mutation of et(IV) gene in this case. However, since more than 50 different mutations have been identified in the COL4A5 gene but none in the COL4A6 gene, it is possible that a heterotrimeric molecule composed of the three chains, a3, a4, and e~5, cannot be formed due to abnormal cd chain synthesized from a mutated COL4A5 gene.
In addition to the human and murine al(fV) and et2(IV) collagen genes (Killen et al., 1988; Soininen et al., 1988) , there are several clustered genes in vertebrates that are organized in a head-to-head configuration and directed by bidirectional promoters. These include the histone H2a and H2b genes (Hentschel and Birnstiel, 1981) , D H F R and mismatch repair protein 1 gene (Fujii et al., 1992) , Wilms' tumor locus (Huang et al., 1990 ), a proliferation cell nuclear antigen gene (Rizzo et al., 1990) , an SV40-1ike monkey genomic locus (Saffer et al., 1984) , the GPAT/ AIRC genes (Gavalas et al., 1993; Gavalas and Zalkin, 1995) , and Drosophila ras2/rop genes (Lightfoot et al., 1994) . Some of the promoters of these genes are bidirectional but the opposite genes are not identified. The promoter activity for one direction is quite different from that for the other direction, 10-fold different in some cases (Gavalas and Zalkin, 1995) . Most of the paired genes are not homologous at all, however, the COL4A1/COL4A2 and COL4A5/COL4A6 genes are homologous, indicating that the clusters did evolve by gene duplication. Divergent transcription of the two genes from a bidirectional promoter can thus provide coexpression and coregulation of expression in some tissues. Proximal cis-acting elements as well as trans-acting factors such as CTC binding factor (Fischer et al., 1993) have the potential to modulate the expression of both genes simultaneously.
The genes for c~5(IV) and c~6(IV) chains are encoded on opposite D N A strands and have a common promoter region . A question that arose immediately when we noticed the specialized relation of these genes was whether these genes always produce the two chains at a steady rate as COL4A1 and COL4A2 genes do. As we demonstrated in Fig. 6 , keratinocytes, esophageal smooth muscle cells, fat ceils, striated muscle cells and placental epithelial cells express a5(IV) and a6(IV) genes, whereas hepatocytes and cardiac muscle cells do not express either gene. However, of interest was that skeletal muscle cells only synthesized a6(IV) chain and that the glomerular basement membranes were positive with only with c~5(IV) antibody in adult humans. These results are consistent with the analysis of transcripts found in a variety of tissues except for the heart (Zhou et al., 1993) , although we have not analyzed tissues from human fetuses. The two genes are transcribed in the opposite direction in a tissue-specific manner, and regulation of expression for the two genes is controlled at the transcription level. One of the clues for the gene expression could be the presence of the alternative promoters on the COL4A6 gene . The two different transcription forms for the c~6(IV) gene driven by the alternative promoters are found in a tissue-specific manner. The tissue-specific distribution of the newly discovered c~5(IV) and et6(IV) chains are probably related to the specialized function of individual basement membranes in different tissues.
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Received for publication 19 November 1994 and in revised form 4 April 1995. Figure 8 , Distribution of a ( I V ) chains in dermal b a s e m e n t m e m b r a n e from Alport s y n d r o m e patient. Since a similar staining pattern was obtained with cd(IV) and c~2(IV) antibodies in b a s e m e n t m e m b r a n e s of dermal epidermal junction and capillaries, only the c,2(IV) staining pattern (A, with H21) is shown in n o r m a l skin. B o t h a5(IV) (B, H52) and a6(IV) (C, H63) antibodies stain only the dermal b a s e m e n t m e m b r a n e but not that of the capillaries. In the Alport patient case, a similar staining pattern was obtained for a l ( I V ) (not shown) and ~x2(IV) chains as in n o r m a l skin (G); however no clear staining was s h o w n by m o n o c l o n a l antibodies for ~5(IV) (H) and c~6(IV) (/) chains at all ( H a n d / ) . Phase-contrast images are shown for individual samples in n o r m a l skin ( D -F ) and A l p o r t skin (J-L).
